BR9712014A - Prepara-Æo de 1-butil-4-piperidinil metil amina - Google Patents

Prepara-Æo de 1-butil-4-piperidinil metil amina

Info

Publication number
BR9712014A
BR9712014A BR9712014A BR9712014A BR9712014A BR 9712014 A BR9712014 A BR 9712014A BR 9712014 A BR9712014 A BR 9712014A BR 9712014 A BR9712014 A BR 9712014A BR 9712014 A BR9712014 A BR 9712014A
Authority
BR
Brazil
Prior art keywords
butyl
preparation
methyl amine
piperidinyl methyl
piperidinyl
Prior art date
Application number
BR9712014A
Other languages
English (en)
Inventor
Michael Fedouloff
David William Guest
Gillian Elizabeth Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9712014A publication Critical patent/BR9712014A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Optical Couplings Of Light Guides (AREA)
BR9712014A 1996-09-11 1997-09-09 Prepara-Æo de 1-butil-4-piperidinil metil amina BR9712014A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9618967.5A GB9618967D0 (en) 1996-09-11 1996-09-11 Pharmaceuticals
PCT/EP1997/005167 WO1998011067A1 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine

Publications (1)

Publication Number Publication Date
BR9712014A true BR9712014A (pt) 1999-08-24

Family

ID=10799764

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712014A BR9712014A (pt) 1996-09-11 1997-09-09 Prepara-Æo de 1-butil-4-piperidinil metil amina

Country Status (30)

Country Link
US (1) US6331631B1 (pt)
EP (1) EP0927163B1 (pt)
JP (2) JP3748570B2 (pt)
KR (1) KR100525703B1 (pt)
CN (1) CN1102927C (pt)
AR (1) AR008174A1 (pt)
AT (1) ATE358121T1 (pt)
AU (1) AU725210B2 (pt)
BR (1) BR9712014A (pt)
CA (1) CA2266468C (pt)
CO (1) CO4930263A1 (pt)
CY (1) CY2590B2 (pt)
CZ (1) CZ290932B6 (pt)
DE (1) DE69737529T2 (pt)
DK (1) DK0927163T3 (pt)
ES (1) ES2285732T3 (pt)
GB (1) GB9618967D0 (pt)
HK (1) HK1020963A1 (pt)
HU (1) HUP9904155A3 (pt)
IL (1) IL128785A0 (pt)
NO (1) NO312587B1 (pt)
NZ (1) NZ334272A (pt)
PL (1) PL191373B1 (pt)
PT (1) PT927163E (pt)
SA (1) SA97180387B1 (pt)
SI (1) SI0927163T1 (pt)
TR (1) TR199900493T2 (pt)
TW (1) TW432048B (pt)
WO (1) WO1998011067A1 (pt)
ZA (1) ZA978087B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals
US20020091271A1 (en) 1998-07-16 2002-07-11 Smithkline Beecham Plc Process for the preparation of an indole derivative
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
CN104557672B (zh) * 2015-01-26 2016-09-21 湖南华腾制药有限公司 一种1位取代哌啶衍生物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821904B2 (ja) * 1975-04-04 1983-05-04 住友化学工業株式会社 シンキナメタノ−アントラセンユウドウタイノセイゾウホウホウ
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
AT394715B (de) * 1990-08-14 1992-06-10 Chemie Linz Gmbh Verfahren zur n-alkylierung von harnstoffen
EP0604494B1 (en) * 1991-09-12 1999-07-28 Smithkline Beecham Plc 5-ht4 receptor antagonists
MA22647A1 (fr) * 1991-09-14 1993-04-01 Smithkline Beecham Plc Procede de preparation d'un ester ou d'un amide d'un nouveau produit .
EP0884319B1 (en) * 1992-03-12 2004-05-06 SmithKline Beecham plc N- (1-nButyl-4-piperidyl)methyl -3,4-dihydro-2H- 1,3 oxazino 3,2-a indole-10-carboxamide or a pharmaceutically acceptable salt thereof
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5726187A (en) * 1992-10-16 1998-03-10 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
DE4427836A1 (de) * 1994-08-05 1996-02-08 Hoechst Ag Verbindungen aus der Reihe der Phosphane, Verfahren zu ihrer Herstellung sowie ihre Verwendung
WO1996038420A1 (fr) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Derives de l'indazole a groupe amino monocyclique
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
DE69737529D1 (de) 2007-05-10
NZ334272A (en) 2000-08-25
IL128785A0 (en) 2000-01-31
TR199900493T2 (xx) 1999-06-21
CZ290932B6 (cs) 2002-11-13
CN1102927C (zh) 2003-03-12
CN1230179A (zh) 1999-09-29
NO991148D0 (no) 1999-03-10
HUP9904155A2 (hu) 2000-05-28
CZ80999A3 (cs) 1999-11-17
US6331631B1 (en) 2001-12-18
CA2266468C (en) 2005-10-25
AR008174A1 (es) 1999-12-09
PL332088A1 (en) 1999-08-30
HK1020963A1 (en) 2000-05-26
EP0927163B1 (en) 2007-03-28
JP2005220126A (ja) 2005-08-18
WO1998011067A1 (en) 1998-03-19
DE69737529T2 (de) 2008-01-31
CY2590B2 (en) 2009-11-04
SI0927163T1 (sl) 2007-08-31
DK0927163T3 (da) 2007-08-06
CA2266468A1 (en) 1998-03-19
AU4776497A (en) 1998-04-02
NO991148L (no) 1999-03-10
PT927163E (pt) 2007-07-06
GB9618967D0 (en) 1996-10-23
TW432048B (en) 2001-05-01
ZA978087B (en) 1999-03-09
JP2001500148A (ja) 2001-01-09
NO312587B1 (no) 2002-06-03
EP0927163A1 (en) 1999-07-07
JP3748570B2 (ja) 2006-02-22
KR100525703B1 (ko) 2005-11-03
HUP9904155A3 (en) 2001-01-29
KR20000038041A (ko) 2000-07-05
SA97180387B1 (ar) 2006-11-04
PL191373B1 (pl) 2006-05-31
ATE358121T1 (de) 2007-04-15
ES2285732T3 (es) 2007-11-16
AU725210B2 (en) 2000-10-05
CO4930263A1 (es) 2000-06-27

Similar Documents

Publication Publication Date Title
NO993068L (no) Ny forbindelsesform
IS2325B (is) Örgerðar samsetningar epleróns
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
PT1066027E (pt) Composicao farmaceutica de topiramato
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
IS5245A (is) Lyfjablanda úr ómeprasól
PT1128831E (pt) Preparacao farmaceutica de moxifloxacina
PT907364E (pt) Composicao farmaceutica de libertacao sustida
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
PT868183E (pt) Formulacoes injectaveis de quinolona
ATE314387T1 (de) Dolastatin 15 derivate
DE69812461D1 (de) Gelenkschutz
ID17860A (id) Komposisi vaksin
NO20002126D0 (no) Formulering med forlenget frigjøring
NO982473D0 (no) 5'-Deoksy-cytidinderivater
EE04154B1 (et) Omeprasooli valmistamise meetod
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
ID16838A (id) Komposisi dekafluoropentana
BR9712014A (pt) Prepara-Æo de 1-butil-4-piperidinil metil amina
FI951155A (fi) Farmaseuttinen valmiste
ITMI981796A0 (it) Procedimento per la preparazione di r-(-)-carnitina
BR9708718A (pt) Sínteses de aminas substituídas
IT1293819B1 (it) Procedimento per la preparazione di acarbosio

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time